BRAINSTORM CELL THERAPEUTICS's ticker is BCLI and the CUSIP is 10501E201. A total of 94 filers reported holding BRAINSTORM CELL THERAPEUTICS in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,259 | -90.3% | 11,287 | 0.0% | 0.00% | – |
| Q2 2023 | $23,251 | -37.6% | 11,287 | 0.0% | 0.00% | – |
| Q1 2023 | $37,247 | +101.2% | 11,287 | 0.0% | 0.00% | – |
| Q4 2022 | $18,511 | -63.0% | 11,287 | 0.0% | 0.00% | – |
| Q3 2022 | $50,000 | +56.2% | 11,287 | 0.0% | 0.00% | – |
| Q2 2022 | $32,000 | -15.8% | 11,287 | 0.0% | 0.00% | – |
| Q1 2022 | $38,000 | -17.4% | 11,287 | 0.0% | 0.00% | – |
| Q4 2021 | $46,000 | +21.1% | 11,287 | 0.0% | 0.00% | – |
| Q3 2021 | $38,000 | -11.6% | 11,287 | 0.0% | 0.00% | – |
| Q2 2021 | $43,000 | -85.7% | 11,287 | -85.6% | 0.00% | – |
| Q1 2021 | $300,000 | +1.4% | 78,115 | +19.7% | 0.00% | – |
| Q4 2020 | $296,000 | -75.2% | 65,240 | -7.6% | 0.00% | -100.0% |
| Q3 2020 | $1,195,000 | +54.8% | 70,593 | +2.6% | 0.00% | – |
| Q2 2020 | $772,000 | +1356.6% | 68,781 | +509.4% | 0.00% | – |
| Q1 2020 | $53,000 | +8.2% | 11,287 | 0.0% | 0.00% | – |
| Q4 2019 | $49,000 | +8.9% | 11,287 | 0.0% | 0.00% | – |
| Q3 2019 | $45,000 | 0.0% | 11,287 | 0.0% | 0.00% | – |
| Q2 2019 | $45,000 | -8.2% | 11,287 | 0.0% | 0.00% | – |
| Q1 2019 | $49,000 | – | 11,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Weaver Consulting Group | 130,000 | $437,000 | 0.21% |
| Ikarian Capital, LLC | 304,161 | $1,022,000 | 0.13% |
| ABNER HERRMAN & BROCK LLC | 265,000 | $890,000 | 0.12% |
| S.C. Financial Services, Inc. | 15,285 | $51,000 | 0.06% |
| JMAC ENTERPRISES LLC | 45,430 | $153,000 | 0.04% |
| CFO4Life Group, LLC | 12,000 | $40,000 | 0.01% |
| OSAIC HOLDINGS, INC. | 10,839 | $1,329,000 | 0.00% |
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 3,000 | $10,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 29,186 | $98,000 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 190,403 | $640,000 | 0.00% |